Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Extraintestinal Entamoeba histolytica amebiasis

INTRODUCTION

Amebiasis is caused by the protozoan Entamoeba histolytica. Most infections are asymptomatic; clinical manifestations include amebic dysentery and extraintestinal disease. Worldwide, approximately 40 to 50 million people are infected annually [1]. Extraintestinal manifestations include amebic liver abscess and other more rare manifestations such as pulmonary, cardiac, and brain involvement [2].

The extraintestinal manifestations of amebiasis will be reviewed here. Issues related to intestinal infection with E. histolytica are discussed separately, including epidemiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prevention. (See "Intestinal Entamoeba histolytica amebiasis".)

AMEBIC LIVER ABSCESS

Amebic liver abscess is the most common extraintestinal manifestation of amebiasis. Amebae establish hepatic infection by ascending the portal venous system [3].

Epidemiology — Amebic liver abscess (and other extraintestinal disease) is 7 to 10 times more common among adult men than other demographic groups, despite equal gender distribution of colonic amebic disease [4-7]. It is observed most frequently in the fourth and fifth decades of life [8]. The reasons for these observations are not fully understood; suggested mechanisms include hormonal effects and a potential role of alcoholic hepatocellular damage in creating a nidus for portal seeding [6].

In developed countries, amebiasis is generally seen in migrants from and travelers to endemic areas. Areas with high rates of amebic infection include India, Africa, Mexico, and parts of Central and South America. Amebiasis is relatively uncommon among short-term travelers, but amebic liver abscesses can occur after travel exposures as short as four days [9]. In one study, 35 percent of travelers with amebic liver abscess had spent less than six weeks in an endemic area [10].

                  

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Oct 2014. | This topic last updated: Nov 3, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Li E, Stanley SL Jr. Protozoa. Amebiasis. Gastroenterol Clin North Am 1996; 25:471.
  2. Haque R, Huston CD, Hughes M, et al. Amebiasis. N Engl J Med 2003; 348:1565.
  3. Aikat BK, Bhusnurmath SR, Pal AK, et al. The pathology and pathogenesis of fatal hepatic amoebiasis--A study based on 79 autopsy cases. Trans R Soc Trop Med Hyg 1979; 73:188.
  4. Maltz G, Knauer CM. Amebic liver abscess: a 15-year experience. Am J Gastroenterol 1991; 86:704.
  5. Acuna-Soto R, Maguire JH, Wirth DF. Gender distribution in asymptomatic and invasive amebiasis. Am J Gastroenterol 2000; 95:1277.
  6. Stanley SL Jr. Amoebiasis. Lancet 2003; 361:1025.
  7. Nattakom S, Serrato P, Bright T, et al. Amebic liver abscesses masquerading as pyemic abscesses. Clin Infect Dis 2001; 33:E145.
  8. Salles JM, Salles MJ, Moraes LA, Silva MC. Invasive amebiasis: an update on diagnosis and management. Expert Rev Anti Infect Ther 2007; 5:893.
  9. Aucott JN, Ravdin JI. Amebiasis and "nonpathogenic" intestinal protozoa. Infect Dis Clin North Am 1993; 7:467.
  10. Knobloch J, Mannweiler E. Development and persistence of antibodies to Entamoeba histolytica in patients with amebic liver abscess. Analysis of 216 cases. Am J Trop Med Hyg 1983; 32:727.
  11. Park WB, Choe PG, Jo JH, et al. Amebic liver abscess in HIV-infected patients, Republic of Korea. Emerg Infect Dis 2007; 13:516.
  12. Petri WA, Singh U. Enteric amebiasis. In: Tropical infectious diseases: Principles, pathogens, and practice, 2nd ed, Guerrant R, Walker DH, Weller PF (Eds), Elsevier, Philadelphia 2006. p.967.
  13. Adams EB, MacLeod IN. Invasive amebiasis. I. Amebic dysentery and its complications. Medicine (Baltimore) 1977; 56:315.
  14. Sodhi KS, Ojili V, Sakhuja V, Khandelwal N. Hepatic and inferior vena caval thrombosis: vascular complication of amebic liver abscess. J Emerg Med 2008; 34:155.
  15. Wu KS, Tsai HC, Lee SS, et al. Comparison of clinical characteristics of amebic liver abscess in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. J Microbiol Immunol Infect 2008; 41:456.
  16. Ravdin JI. Amebiasis. Clin Infect Dis 1995; 20:1453.
  17. Stockinger ZT. Colonic ameboma: its appearance on CT: report of a case. Dis Colon Rectum 2004; 47:527.
  18. Misra SP, Misra V, Dwivedi M. Ileocecal masses in patients with amebic liver abscess: etiology and management. World J Gastroenterol 2006; 12:1933.
  19. Katzenstein D, Rickerson V, Braude A. New concepts of amebic liver abscess derived from hepatic imaging, serodiagnosis, and hepatic enzymes in 67 consecutive cases in San Diego. Medicine (Baltimore) 1982; 61:237.
  20. Pritt BS, Clark CG. Amebiasis. Mayo Clin Proc 2008; 83:1154.
  21. Park MS, Kim KW, Ha HK, Lee DH. Intestinal parasitic infection. Abdom Imaging 2008; 33:166.
  22. Benedetti NJ, Desser TS, Jeffrey RB. Imaging of hepatic infections. Ultrasound Q 2008; 24:267.
  23. Thorsen S, Rønne-Rasmussen J, Petersen E, et al. Extra-intestinal amebiasis: clinical presentation in a non-endemic setting. Scand J Infect Dis 1993; 25:747.
  24. Patterson M, Healy GR, Shabot JM. Serologic testing for amoebiasis. Gastroenterology 1980; 78:136.
  25. Joyce MP, Ravdin JI. Antigens of Entamoeba histolytica recognized by immune sera from liver abscess patients. Am J Trop Med Hyg 1988; 38:74.
  26. Stanley SL Jr, Jackson TF, Foster L, Singh S. Longitudinal study of the antibody response to recombinant Entamoeba histolytica antigens in patients with amebic liver abscess. Am J Trop Med Hyg 1998; 58:414.
  27. Kraoul L, Adjmi H, Lavarde V, et al. Evaluation of a rapid enzyme immunoassay for diagnosis of hepatic amoebiasis. J Clin Microbiol 1997; 35:1530.
  28. Abd-Alla MD, Jackson TF, Gathiram V, et al. Differentiation of pathogenic Entamoeba histolytica infections from nonpathogenic infections by detection of galactose-inhibitable adherence protein antigen in sera and feces. J Clin Microbiol 1993; 31:2845.
  29. Chavez-Tapia NC, Hernandez-Calleros J, Tellez-Avila FI, et al. Image-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated amoebic liver abscess. Cochrane Database Syst Rev 2009; :CD004886.
  30. Soentjens P, Ostyn B, Clerinx J, et al. A case of multiple amoebic liver abscesses: clinical improvement after percutaneous aspiration. Acta Clin Belg 2005; 60:28.
  31. Khanna S, Chaudhary D, Kumar A, Vij JC. Experience with aspiration in cases of amebic liver abscess in an endemic area. Eur J Clin Microbiol Infect Dis 2005; 24:428.
  32. Salata RA, Ravdin JI. The interaction of human neutrophils and Entamoeba histolytica increases cytopathogenicity for liver cell monolayers. J Infect Dis 1986; 154:19.
  33. Sharma MP, Dasarathy S. Amoebic liver abscess. Trop Gastroenterol 1993; 14:3.
  34. Khan U, Mirdha BR, Samantaray JC, Sharma MP. Detection of Entamoeba histolytica using polymerase chain reaction in pus samples from amebic liver abscess. Indian J Gastroenterol 2006; 25:55.
  35. Khokhani RC, Garud AD, Deodhar KP, et al. Treatment of amoebic liver abscess with tinidazole and metronidazole. Drugs 1978; 15 Suppl 1:23.
  36. Ravdin JI, Skilogiannis J. In vitro susceptibilities of Entamoeba histolytica to azithromycin, CP-63,956, erythromycin, and metronidazole. Antimicrob Agents Chemother 1989; 33:960.
  37. Lasserre R, Jaroonvesama N, Kurathong S, Soh CT. Single-day drug treatment of amebic liver abscess. Am J Trop Med Hyg 1983; 32:723.
  38. Quaderi MA, Rahman MS, Rahman A, Islam N. Amoebic liver abscess and clinical experiences with tinidazole in Bangladesh. J Trop Med Hyg 1978; 81:16.
  39. Vanijanonta S, Bunnag D, Looareesuwan S, Harinasuta T. Low dose tinidazole in the treatment of amoebic liver abscess. Southeast Asian J Trop Med Public Health 1985; 16:253.
  40. Rossignol JF, Kabil SM, El-Gohary Y, Younis AM. Nitazoxanide in the treatment of amoebiasis. Trans R Soc Trop Med Hyg 2007; 101:1025.
  41. Sharma MP, Dasarathy S, Verma N, et al. Prognostic markers in amebic liver abscess: a prospective study. Am J Gastroenterol 1996; 91:2584.
  42. Kenner BM, Rosen T. Cutaneous amebiasis in a child and review of the literature. Pediatr Dermatol 2006; 23:231.
  43. Shamsuzzaman SM, Hashiguchi Y. Thoracic amebiasis. Clin Chest Med 2002; 23:479.
  44. Adams EB, MacLeod IN. Invasive amebiasis. II. Amebic liver abscess and its complications. Medicine (Baltimore) 1977; 56:325.
  45. Brandt H, Tamayo RP. Pathology of human amebiasis. Hum Pathol 1970; 1:351.
  46. Lyche KD, Jensen WA, Kirsch CM, et al. Pleuropulmonary manifestations of hepatic amebiasis. West J Med 1990; 153:275.
  47. Kennedy D, Sharma OP. Hemoptysis in a 49-year-old man. An unusual presentation of a sporadic disease. Chest 1990; 98:1275.
  48. Wilson ES. Pleuropulmonary amebiasis. Am J Roentgenol Radium Ther Nucl Med 1971; 111:518.
  49. Lichtenstein A, Kondo AT, Visvesvara GS, et al. Pulmonary amoebiasis presenting as superior vena cava syndrome. Thorax 2005; 60:350.
  50. Fung HB, Doan TL. Tinidazole: a nitroimidazole antiprotozoal agent. Clin Ther 2005; 27:1859.
  51. Miyauchi T, Takiya H, Sawamura T, Murakami E. Cardiac tamponade due to intrapericardial rupture of an amebic liver abscess. Jpn J Thorac Cardiovasc Surg 2005; 53:206.
  52. Schmutzhard E, Mayr U, Rumpl E, et al. Secondary cerebral amebiasis due to infection with Entamoeba histolytica. A case report with computer tomographic findings. Eur Neurol 1986; 25:161.